Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats-Reference-Cited by-同舟云学术

Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats

Published:2021-05-20 Issue:6 Volume:18 Page:2208-2217
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Jakubiak Paulina¹^ORCID,Alvarez-Sánchez Rubén¹^ORCID,Fueth Matthias¹,Broders Olaf²,Kettenberger Hubert³,Stubenrauch Kay²,Caruso Antonello¹^ORCID

Affiliation:

1. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland

2. Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, F. Hoffmann-La Roche Ltd., Nonnenwald 2, D-82377 Penzberg, Germany

3. Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, F. Hoffmann-La Roche Ltd., Nonnenwald 2, D-82377 Penzberg, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c01218

Reference53 articles.

1. Drug discovery in ophthalmology: past success, present challenges, and future opportunities

2. Drug delivery to the posterior segment of the eye for pharmacologic therapy

3. Ocular Drug Delivery

4. Anti-VEGF Treatment Strategies for Wet AMD

5. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of DNA aptamers universally bound to single-chain fragment variables and their applications in bioprocess monitoring;Biosensors and Bioelectronics;2024-10

2. Age-Related Macular Degeneration and its Current Treatment Strategies: An Updated Review;Macular Diseases - An Update;2024-02-09

3. Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice;Cancers;2024-01-13

4. Development of an Expression Vector Engineering Strategy Based on tDNA Insulator Element for the Stable Expression of Vascular Endothelial Growth Factor Receptor-Fc Fusion Protein;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-08-01

5. Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration;Cureus;2023-06-07